Pharma Components ApS: Financial statements 2020
CVR: 39103079
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Pharma Components ApS (CVR 39103079) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -17,308 and a net result of DKK -15,388 compared with DKK 34,882 the year before. Equity in the 2020 report amounted to DKK 15,120. The solvency ratio was 18.7%.
- Gross Profit
- DKK -17,308
- Profit/Loss
- DKK -15,388
- Equity
- DKK 15,120
- Total Assets
- DKK 80,851
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -17 t. | -15 t. | 15 t. | 0 |
| 2019 | - | 45 t. | 35 t. | 31 t. | - |
How creditworthy is Pharma Components ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
On November 13, 2020, the company changed its name from Pharma Components IVS to Pharma Components ApS.
Pharma Components ApS has published its annual report for 2019. Gross profit came to DKK 45,332, and the net result was DKK 34,882.
About Pharma Components ApS
Pharma Components ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2017. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named Pharma Components IVS. The management consists of Anders Fossing Riel. The company is owned by A.Rocket Holding ApS. In 2025, the company reported a gross profit of DKK -35,183 and a net result of DKK -115,173 compared with DKK 142,048 the year before. Equity in the 2025 report amounted to DKK 272,393.